UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 9, 2022 5:00 P.M.

Form:	S-3
CIK: 0001807120 Company Name: Design Therapeutics, Inc. File Number: 333-264521